HLA-DRA/HLA-DRB5 polymorphism affects risk of sporadic ALS and survival in a southwest Chinese cohort

18Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Introduction Frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD) are neurodegenerative diseases that share common genetic risk factors. A recent genome-wide association study has linked risk of FTD with polymorphisms in the HLA-DRA/HLA-DRB5 gene (rs9268877, rs9268856), BTNL2 gene (rs1980493), and RAB38/CTSC gene (rs302668). Methods We used the SNPscan™ Kit to genotype these variants in 400 Chinese patients with sporadic ALS, 554 with sporadic PD and 634 healthy controls. Results The AA genotype at rs9268856 increased risk of ALS (P�=�0.005). Mean survival time was significantly shorter in patients with the AA genotype (24.8���16.2�months) than in patients with other genotypes (36.9���19.9�months; P�

Cite

CITATION STYLE

APA

Yang, X., Zheng, J. H., Tian, S., Chen, Y., An, R., Zhao, Q., & Xu, Y. (2017). HLA-DRA/HLA-DRB5 polymorphism affects risk of sporadic ALS and survival in a southwest Chinese cohort. Journal of the Neurological Sciences, 373, 124–128. https://doi.org/10.1016/j.jns.2016.12.055

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free